project id: TCGA-THCA; case submitter id: TCGA-EL-A3CU; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.84; concentration: 0.16; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.8; rna integrity number: 8.7; age at index: 70; days to birth: -25881; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1930; age at diagnosis: 25881; ajcc pathologic m: M0; ajcc pathologic n: N1a; ajcc pathologic stage: Stage III; ajcc pathologic t: T1; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 4780.0; icd 10 code: C73; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Thyroid gland; synchronous malignancy: No; tissue or organ of origin: Thyroid gland; tumor grade: Not Reported; year of diagnosis: 2000; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 4278; days to sample procurement: 0; initial weight: 240.0; portion submitter id: TCGA-EL-A3CU-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 85.0; percent tumor nuclei: 85.0;